Filana Therapeutics, Inc. (NASDAQ:FLNA)
| Market Cap | 21.87M-77.9% |
| Revenue (ttm) | 0 |
| Net Income | -42.20M+60.2% |
| EPS | -0.87+60.3% |
| Shares Out | 48.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 605,611 |
| Open | 0.46 |
| Previous Close | 0.45 |
| Day's Range | 0.43 - 0.47 |
| 52-Week Range | 0.43 - 3.45 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
3 qualifying trades · 1 insider · $356.33K bought in the last 90 days
Filana Therapeutics, Inc. Stock Analysis — InsiderScore
See top-rated InsiderScore stocks ›Filana Therapeutics, Inc. scored higher than 80% of companies evaluated by InsiderBuying, and ranked 15th out of 99 stocks in the biotech sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Filana Therapeutics, Inc. bought $356.3K of stock across 3 purchases in the last 90 days, the largest of them $186.1K.
The average purchase added about 13% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
About FLNA
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Insider buys and sells on the price
1 year · open-market trades onlyAsk Barron about FLNA
$FLNA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in FLNA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by FLNA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
FLNA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New FLNA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to FLNA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in FLNA
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.21M |
| VXFVanguard Extended Market ETF | $499.60K |
| VHTVanguard Health Care ETF | $119.02K |
| IWCiShares Micro-Cap ETF | $67.40K |
Estimated from each fund’s disclosed top holdings × AUM
FLNA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from FLNA’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
Biotech: ranks #15 of 99 scored Biotech stocks · sector average 59.3
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
+7.6 since Oct 1Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.